|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 3 (February 1), 2000:
pp. 870-878
Characterization of hematopoietic lineage-specific gene
expression by ES cell in vitro differentiation induction system
Takumi Era,
Toshiaki Takagi,
Tomomi Takahashi,
Jean-Christophe Bories, and
Toru Nakano
From the Department of Molecular Cell Biology, Research Institute
for Microbial Diseases, Osaka University, Osaka, Japan; and Unité
462 Institut National de la Santé et de la Recherche
Médicale, Hôpital Saint-Louis, Paris, France.
The continuous generation of mature blood cells from hematopoietic
progenitor cells requires a highly complex series of molecular events.
To examine lineage-specific gene expression during the differentiation
process, we developed a novel method combining LacZ reporter gene analysis with in vitro
hematopoietic differentiation induction from mouse embryonic stem
cells. For a model system using this method, we chose the erythroid and
megakaryocytic differentiation pathways. Although erythroid and
megakaryocytic cells possess distinct functional and morphologic
features, these 2 lineages originate from bipotential
erythro-megakaryocytic progenitors and share common lineage-restricted
transcription factors. A portion of the 5' flanking region of the
human glycoprotein IIb ( IIb) integrin gene extending from base
 598 to base +33 was examined in detail. As reported previously,
this region is sufficient for megakaryocyte-specific gene expression.
However, previous reports that used human erythro-megakaryocytic cell
lines suggested that one or more negative regulatory regions were
necessary for megakaryocyte-specific gene expression. Our data clearly
showed that an approximately 200-base enhancer region extending from
598 to 400 was sufficient for megakaryocyte-specific gene
expression. This experimental system has advantages over those using
erythro-megakaryocytic cell lines because it recapitulates normal
hematopoietic cell development and differentiation. Furthermore, this
system is more efficient than transgenic analysis and can easily
examine gene expression with null mutations of specific genes.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. L. Olsen, D. L. Stachura, and M. J. Weiss
Designer blood: creating hematopoietic lineages from embryonic stem cells
Blood,
February 15, 2006;
107(4):
1265 - 1275.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Stachura, S. T. Chou, and M. J. Weiss
Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1
Blood,
January 1, 2006;
107(1):
87 - 97.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Vodyanik, J. A. Bork, J. A. Thomson, and I. I. Slukvin
Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential
Blood,
January 15, 2005;
105(2):
617 - 626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Umeda, T. Heike, M. Yoshimoto, M. Shiota, H. Suemori, H. Y. Luo, D. H. K. Chui, R. Torii, M. Shibuya, N. Nakatsuji, et al.
Development of primitive and definitive hematopoiesis from nonhuman primate embryonic stem cells in vitro
Development,
April 15, 2004;
131(8):
1869 - 1879.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-T. Fujimoto, S. Kohata, H. Suzuki, H. Miyazaki, and K. Fujimura
Production of functional platelets by differentiated embryonic stem (ES) cells in vitro
Blood,
December 1, 2003;
102(12):
4044 - 4051.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Elagib, F. K. Racke, M. Mogass, R. Khetawat, L. L. Delehanty, and A. N. Goldfarb
RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation
Blood,
June 1, 2003;
101(11):
4333 - 4341.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Senju, S. Hirata, H. Matsuyoshi, M. Masuda, Y. Uemura, K. Araki, K.-i. Yamamura, and Y. Nishimura
Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells
Blood,
May 1, 2003;
101(9):
3501 - 3508.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Eto, R. Murphy, S. W. Kerrigan, A. Bertoni, H. Stuhlmann, T. Nakano, A. D. Leavitt, and S. J. Shattil
Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling
PNAS,
October 1, 2002;
99(20):
12819 - 12824.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Furihata and T. J. Kunicki
Characterization of Human Glycoprotein VI Gene 5' Regulatory and Promoter Regions
Arterioscler Thromb Vasc Biol,
October 1, 2002;
22(10):
1733 - 1739.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Lian, M. Maeda, S. Lohwasser, M. Delcommenne, T. Nakano, R. E. Vance, D. H. Raulet, and F. Takei
Orderly and Nonstochastic Acquisition of CD94/NKG2 Receptors by Developing NK Cells Derived from Embryonic Stem Cells In Vitro
J. Immunol.,
May 15, 2002;
168(10):
4980 - 4987.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Eisbacher, L. M. Khachigian, T. H. Khin, M. L. Holmes, and B. H. Chong
Inducible Expression of the Megakarocyte-specific Gene Glycoprotein IX Is Mediated through an Ets Binding Site and Involves Upstream Activation of Extracellular Signal-regulated Kinase
Cell Growth Differ.,
August 1, 2001;
12(8):
435 - 445.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Car and V. M. Eng
Special Considerations in the Evaluation of the Hematology and Hemostasis of Mutant Mice
Vet. Pathol.,
January 1, 2001;
38(1):
20 - 30.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. K. Racke, D. Wang, Z. Zaidi, J. Kelley, J. Visvader, J.-W. Soh, and A. N. Goldfarb
A Potential Role for Protein Kinase C-epsilon in Regulating Megakaryocytic Lineage Commitment
J. Biol. Chem.,
January 5, 2001;
276(1):
522 - 528.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
